Dilinie Fernando

Dilinie Fernando currently holds the position of Senior Scientist II at Kestrel Therapeutics since September 2023. Previously, Dilinie served as a Senior Scientist I and Scientist II at Blueprint Medicines from February 2020 to September 2023, with a focus on medicinal chemistry. Prior experience includes roles as a Sr. Associate Scientist in medicinal chemistry at Amgen (July 2017 - December 2019), Scientist at Pfizer (December 2007 - July 2017), and Chemist in process chemistry at Abbott (February 2000 - December 2007), as well as a Summer Intern at Abbott in 1999. Dilinie earned a Master’s degree in Organic Chemistry from Washington State University and a Bachelor of Science degree in Chemistry from North Dakota State University.